The environment significantly influences whether or not a certain bacterium will block mosquitoes from transmitting malaria, according to researchers at Penn State.
Feb 17, 2014
0
0
The parasites that cause malaria are exquisitely adapted to the various hosts they infect—so studying the disease in mice doesn't necessarily reveal information that could lead to drugs effective against human disease.
Jan 13, 2014
0
0
(Medical Xpress)—A novel malaria vaccine developed at Oxford University has shown promising results in the first clinical trial to test whether it can protect people against the mosquito-borne disease.
Nov 29, 2013
0
0
A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.
Nov 13, 2013
0
0
A new link between meal times and daily changes in the immune system has been identified by UC San Francisco researchers, and has led them to question assumptions about the roles of specific immune cells in infection and ...
Sep 16, 2013
0
0
An investigational malaria vaccine has been found to be safe, to generate an immune system response, and to offer protection against malaria infection in healthy adults, according to the results of an early-stage clinical ...
Aug 8, 2013
0
0
Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites growing inside red ...
Jun 5, 2013
0
0
(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.
May 30, 2013
0
0
(Medical Xpress)—Labs around the world, and a core group at Penn, have been studying recently described populations of immune cells called innate lymphoid cells (ILCs). Some researchers liken them to foot soldiers that ...
May 14, 2013
0
0
Scientists at The Scripps Research Institute (TSRI) have found a telltale molecular marker for Onchocerciasis or "river blindness," a parasitic infection that affects tens of millions of people in Africa, Latin America and ...
Feb 25, 2013
0
0
